this unlikely.
Treatment options include antiplatelet therapy, immunosuppression and anticoagulation. Aspirin, which lowers the rate of fetal loss in the syndrome (in conjunction with low-dose subcutaneous heparin), may have a place for primary prophylaxis in those with high titres of antiphospholipid antibodies. Immunosuppression can lower titres of anticardiolipin antibodies but does not always prevent recurrence of thrombosis5 or improve other aspects of the syndrome. In patients with a proven thrombotic event lifelong anticoagulation is currently the most satisfactory therapeutic strategy. The hazards of anticoagulation in a patient with longstanding controlled hypertension are difficult to quantify, but in this case we felt that they were outweighed by the risk of further vasculopathy. In most industrialized countries prostatic adenocarcinoma is the second most common cause of cancer death in men. We report a case that highlights the value of prostatic immunoscintigraphy in management.
CASE HISTORY
A man aged 62 had urinary retention following haemorrhoidectomy. There were no previous symptoms of bladder outflow obstruction and he was in good general health. On digital rectal examination the prostate gland was smooth and symmetrically enlarged. Serum prostate specific antigen (PSA) was raised at 7.7/,g/L (normal <4,ug/L). A transrectal ultrasound scan showed a well-defined hypoechoic area with increased colour flow in the right anterior gland. Four ultrasound-guided systematic biopsies were taken, with 18 gauge needle and automatic biopsy gun, from the lesion, from the right and left lobes and from the apex and a well-differentiated adenocarcinoma ( Figure 1 ) was identified at the site of the ultrasonographic abnormality. The other biopsies were clear, and a scintigraphic bone scan showed no metastatic lesions.
Presented with the therapeutic options, the patient elected to undergo radical prostatectomy. This was done, with pelvic lymphadenectomy, 17 weeks later. Whole mount sections of the prostate (Figure 2 ) at 5 mm intervals revealed no tumour, but an abscess cavity 1.5 cm in diameter extended from base to apex of the gland in the region of the positive biopsy. Obturator nodes taken from left and right sides seemed free of metastatic carcinoma. The patient made a good postoperative recovery and by six months had regained full continence and potency. At nine months he complained of mild low back pain which radiated to the left buttock and thigh. Spinal X-rays showed degenerative changes only and he responded well to simple analgesia and a course of physiotherapy. By twenty-two months the pain had become persistent and, although a further bone scan showed no evidence of skeletal metastases, PSA had again become detectable (2 jug/L). Prostatic immunoscintigraphic single photon emission tomography (SPET) with indium-111 radiolabelled monoclonal antibody to prostate membrane specific antigen (PMSA) demonstrated abnormal uptake in the prostatic bed ( Figure 3 ) and adjacent to the iliac vessels ( Figure 4 ), consistent with local recurrence and bilateral iliac lymph Figure 4 Anti-prostate-specific-membrane antigen antibody labelled with "'In. 24-hour single photon emission tomography coronal sections with left more posterior than right. Left: lymph node involvement related to the right iliac vessels. Right: lymph node involvement related to the left iliac vessels (+) . Uptake in the recurrent prostate cancer is seen in both images. Superiorly is hepatic uptake and the tip of the left kidney node metastases. Treatment with bicalutamide (50 mg daily) and goserelin (3.6 mg monthly) led to complete resolution of symptoms and the PSA again became undetectable.
COMMENT
The histological findings at radical prostatectomy suggested that the primary tumour, diagnosed by needle biopsy, had been entirely destroyed by an associated severe inflammatory reaction. In addition, there was no evidence of metastatic spread to regional lymph nodes. Despite these findings, the symptoms and rising PSA level 2 years after surgery suggested the failure of radical prostatectomy in achieving a cure. Though we have no histological proof, the symptomatic response to hormonal treatment is highly suggestive of tumour recurrence.
The phenomenon of minimal or absent adenocarcinoma in prostatectomy specimens has been addressed by Goldstein et al.1. In their series of 13 cases there were 2 in which no tumour could be identified; however, both had received total androgen blockade therapy for two months before surgery. Prostatic immunoscintigraphy is currently under evaluation in the UK2'3. Tissue-specific imaging, achieved by means of an antibody to PMSA labelled with 99mtechnetium or indium-111, allows evaluation of both the primary tumour and metastatic deposits4. This technique has more than double the sensitivity of computerized tomography in the diagnosis of involved lymph nodes5. Most malignant tumours of the larynx and trachea are squamous cell carcinomas. Non-Hodgkin lymphoma (NHL) of the larynx and trachea has been described both in a form localized to the airway and as part of disseminated disease. The diagnosis is often delayed because the symptoms and signs are shared by other conditions1.
CASE HISTORY
A man aged 53, a non-smoker, had had worsening stridor for 10 hours. In the previous 3 months he had become short of breath with progressive hoarseness, weight loss and back pain, and in the three weeks before admission he had developed neck pain and weakness in the right arm. There was no history of sweating episodes or fever. On fibreoptic nasendoscopy the vocal cords were poorly mobile and the right cord was thickened. Head and neck examination was otherwise normal. When intubation failed, an emergency tracheostomy was performed and a biopsy specimen was taken from the tracheal window (morphologically normal). This was followed by direct laryngoscopy with biopsy of a right vocal cord lesion. On immunocytochemistry the tracheal window biopsy specimen showed a grade 2 B-cell non-Hodgkin lymphoma ( Figure  1) ; examination of the laryngeal specimen was inconclusive.
Routine blood tests and bone marrow biopsy were normal. Computed tomography (CT) of the chest was clear. Abdominal CT showed hepatosplenomegaly with a few enlarged lymph nodes in the left para-aortic area and normal pelvis. A radiograph of the cervical spine showed involvement of the fourth cervical vertebra. He received 12 courses of chemotherapy with initially good results, then palliative radiotherapy to the neck. He died eight months after diagnosis, from disseminated disease. COMMENT Most laryngeal NHLs are supraglottic non-ulcerated tumours leading to long-term hoarseness2'3. NHL of the trachea presents with progressive dysphonia, cough and recurrent bronchial infections4.
Lymphoma in the airway is rare. Reviewing all the malignant lesions seen in the professorial unit of the Institute of Laryngology and Otology, London, between 1962 and 1980, Evans found that 5% were lymphoma and less than one-tenth of these involved the larynx or trachea.
Blatsios et al.5 showed that connective tissue malignancies accounted for less than 2% of neoplasia of the larynx and only half were lymphoma. NHL of the larynx and trachea is a systemic disease, so the main purpose of surgery is to obtain biopsy material. On occasion, however, the surgeon may play a greater part.
Weisberger and Davidson6 described a child with extensive involvement of the trachea and larynx and associated cartilage destruction requiring a tracheostomy followed by a laryngotracheoplasty with anterior rib cartilage grafting. 
